Bristol-Myers Squibb: a fresh buy signal, high risk
Bristol-Myers Squibb jumps 5.5%: a fresh buy signal, but a risky entry
Bristol-Myers Squibb: a fresh buy signal, high risk
Our view last week
Bristol-Myers Squibb stalls after its recent rebound: this week the stock dips 0.9%, but money flow keeps climbing and hits a four-week high. Price is boxed between the daily Kumo ceiling and the pivot-point support, both in the 58/57.5 area — a technical pause in the sell signal's management, not a change of course.
This week's summary
Bristol-Myers Squibb rebounds 5.5% this week, a clean bounce off its daily 20-day moving average after a touch in the 57 area. Our model opens a fresh buy signal, but under the surface volumes are contracting and buyer dominance is fading: a case to handle with care, especially with earnings due in two weeks. The quality band flags this opening as high-risk.
IQS Phase
62
ordinary
Signal Strength
50
medium
Sizing
STANDARD
Ranking
#16 / 20
New us stocks
Trade P&L %
+0.00%
from signal to today
restricted Platinum content